{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:42:16Z","timestamp":1789785736852,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.104","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T11:53:24Z","timestamp":1446638004000},"page":"6596-6603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Liping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.104_bib0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000148922","article-title":"Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection","volume":"9","author":"Hagiwara","year":"1978","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0330","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4155\/pbp.14.39","article-title":"Development of picornavirus-like particle vaccines","volume":"3","author":"Somasundaram","year":"2015","journal-title":"Pharm Bioprocess"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virusres.2014.05.006","article-title":"Histopathological features and distribution of EV71 antigens and SCARB2 in human fatal cases and a mouse model of enterovirus 71 infection","volume":"189","author":"Yu","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0345","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10096-011-1432-6","article-title":"Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity","volume":"31","author":"Wang","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0350","doi-asserted-by":"crossref","first-page":"e25662","DOI":"10.1371\/journal.pone.0025662","article-title":"The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008","volume":"6","author":"Tan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0355","doi-asserted-by":"crossref","first-page":"e100545","DOI":"10.1371\/journal.pone.0100545","article-title":"Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-012-0237-z","article-title":"Progress on the research and development of human enterovirus 71 (EV71) vaccines","volume":"7","author":"Liang","year":"2013","journal-title":"Front Med"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0365","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4161\/hv.21739","article-title":"Production of EV71 vaccine candidates","volume":"8","author":"Chong","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0370","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2011.08.030","article-title":"Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin","volume":"44","author":"Zhu","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0375","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jep.2013.02.017","article-title":"Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease","volume":"147","author":"Wang","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0380","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.3390\/molecules170910370","article-title":"Antiviral effect of matrine against human enterovirus 71","volume":"17","author":"Yang","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0385","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/AAC.00101-09","article-title":"Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71","volume":"53","author":"Chen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0390","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.antiviral.2012.12.029","article-title":"Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model","volume":"97","author":"Zhang","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11373-007-9228-5","article-title":"Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants","volume":"15","author":"Chen","year":"2008","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0400","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0405","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/jmv.20579","article-title":"The VP1 protein of human enterovirus 71 self-associates via an interaction domain spanning amino acids 66-297","volume":"78","author":"Lal","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0410","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1371\/journal.pntd.0002895","article-title":"A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved knob region of VP3 protein","volume":"8","author":"Kiener","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0415","doi-asserted-by":"crossref","first-page":"e1003240","DOI":"10.1371\/journal.ppat.1003240","article-title":"The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating","volume":"9","author":"Shingler","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0420","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0425","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1743-422X-9-26","article-title":"Enterovirus 71 viral capsid protein linear epitopes: identification and characterization","volume":"9","author":"Gao","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0430","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1099\/jmm.0.025056-0","article-title":"Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5\u2019 untranslated region and VP1 region","volume":"60","author":"Zhou","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0435","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/317145a0","article-title":"Structure of a human common cold virus and functional relationship to other picornaviruses","volume":"317","author":"Rossmann","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0440","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.1218713","article-title":"Crystal structure of human enterovirus 71","volume":"336","author":"Plevka","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"issue":"5","key":"10.1016\/j.vaccine.2015.10.104_bib0450","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/thno.7457","article-title":"Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop","volume":"4","author":"Xu","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0455","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery","volume":"15","author":"Sette","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0460","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.2174\/138161210793292447","article-title":"Epitope discovery and their use in peptide based vaccines","volume":"16","author":"Dudek","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0465","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0470","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1016\/j.vaccine.2013.06.087","article-title":"Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle","volume":"31","author":"Anggraeni","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0475","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.vaccine.2013.02.013","article-title":"Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)","volume":"31","author":"Rivera-Hernandez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(98)01599-3","article-title":"Hepatitis B core particles as a universal display model: a structure\u2013function basis for development","volume":"442","author":"Pumpens","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0485","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000150415","article-title":"Hepatitis B virus core particles as epitope carriers","volume":"38","author":"Pumpens","year":"1995","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0490","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0168-1656(95)00118-2","article-title":"Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. Presentation of foreign epitopes","volume":"44","author":"Schodel","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0495","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsb.2012.01.005","article-title":"Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry","volume":"177","author":"Bereszczak","year":"2012","journal-title":"J Struct Biol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0500","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1016\/j.vaccine.2011.07.139","article-title":"A candidate dual vaccine against influenza and noroviruses","volume":"29","author":"Xia","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0505","first-page":"124","article-title":"Expression of human PrP gene in prokaryotic cells using GST fusion protein expression system","volume":"13","author":"Zhao","year":"1999","journal-title":"Zhonghua shi yan he lin chuang bing du xue za zhi=Zhonghua shiyan he linchuang bingduxue zazhi"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0510","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/nnm.12.62","article-title":"Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus","volume":"7","author":"Tan","year":"2012","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.10.104_bib0515","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2174\/0929866521666140616120955","article-title":"Development of a norovirus P particle platform for eliciting neutralizing antibody responses to the membrane proximal external region of human immunodeficiency virus type 1 envelope","volume":"21","author":"Zang","year":"2014","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0520","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/MMBR.45.2.287-315.1981","article-title":"Picornaviral structure and assembly","volume":"45","author":"Putnak","year":"1981","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0525","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2014.08.064","article-title":"Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0530","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0535","doi-asserted-by":"crossref","first-page":"31803","DOI":"10.1074\/jbc.M706380200","article-title":"Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies","volume":"282","author":"Bishop","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0540","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1128\/JVI.77.21.11625-11632.2003","article-title":"Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1","volume":"77","author":"Carter","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0545","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","article-title":"Multiple sequence alignment with hierarchical clustering","volume":"16","author":"Corpet","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0550","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4161\/hv.29823","article-title":"Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus A16 infection in newborn mice","volume":"10","author":"Sun","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0555","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0560","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1743-422X-10-250","article-title":"Establishment of cell lines with increased susceptibility to EV71\/CA16 by stable overexpression of SCARB2","volume":"10","author":"Li","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0565","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1080\/21645515.2015.1053675","article-title":"Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice","volume":"11","author":"Sun","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0570","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0575","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1007\/s00253-013-5257-3","article-title":"Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against coxsackievirus A16 in mice","volume":"97","author":"Zhao","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0580","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0585","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jviromet.2012.11.014","article-title":"Development of a coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum","volume":"187","author":"Jin","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0590","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1016\/j.vaccine.2011.04.070","article-title":"Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection","volume":"29","author":"Bek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0595","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease","volume":"84","author":"Ong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0600","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0605","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0610","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2012.06.014","article-title":"Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice","volume":"168","author":"Kolpe","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0615","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0620","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0625","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0630","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0635","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2174\/0929866521666140616120955","article-title":"Development of a norovirus P particle platform for eliciting neutralizing antibody responses to the membrane proximal external region of human immunodeficiency virus type 1 envelope","volume":"21","author":"Zang","year":"2014","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.vaccine.2015.10.104_bib0640","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4149\/av_2015_01_33","article-title":"Production, characterization and immunogenicity of P particles derived from norovirus GII.4 genotype 2004 variant","volume":"59","author":"Su","year":"2015","journal-title":"Acta Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T04:25:08Z","timestamp":1653452708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":64,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015601"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}